MOMENTUM 3 is the largest LVAD trial ever conducted demonstrating excellent survival and safety outcomes with HeartMate 3 LVAD™.
ARIES-HM3 trial is the first and only international randomized controlled trial to study the effects of the avoidance of aspirin on LVAD patients.
This is the first propensity-matched analysis comparing survival outcomes between HeartMate 3 LVAD and heart transplantation in heart failure patients under 50, using data from the MOMENTUM 3 trial and the UNOS registry.
These journal articles help illustrate the clinical evidence for the HeartMate 3 LVAD with Full MagLev™ Flow Technology.
MAT-2313272 v3.0
Stay Connected